Michael Rowbotham
Direktor/Vorstandsmitglied bei The University of California, San Francisco
Profil
Michael Rowbotham has been Chief Medical Officer of Adamas Pharmaceuticals, Inc. since June, 2006.
He is Professor of Neurology and a Director of the Pain Research Center and the Clinical Research, Ernest Gallo Clinic and Research Center at the University of California, San Francisco (UCSF).
Dr. Rowbotham received his BA degree in Biology from the University of California, San Diego and an MD from the University of California, San Francisco.
Aktive Positionen von Michael Rowbotham
Unternehmen | Position | Beginn |
---|---|---|
The University of California, San Francisco | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Rowbotham
Unternehmen | Position | Ende |
---|---|---|
ADAMAS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Michael Rowbotham
The University of California, San Francisco | Doctorate Degree |
University of California San Diego | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |